Walrus (WAL) 24-hour volatility 77.0%: Trading volume surges by $80M driven by Binance activity
Bitget Pulse2026/04/17 02:27Volatility Overview
In the past 24 hours, WAL's price reached a high of $0.1267 and a low of $0.0716. The current price is $0.0764, with a fluctuation amplitude of 77.0%. Trading volume has surged significantly, reaching $108 million to $123 million, more than tripling its normal level.
Reasons for the Anomaly
- Trading Volume Surge: In the past 24 hours, trading volume soared above $80 million, driving a short-term price increase of 29.8%-34.4%.
- Binance Promotional Event: The end of the reward campaign triggered a potential short squeeze, causing the price to rebound from its lows.
Market Views and Outlook
Mainstream sentiment in the community is bullish, regarding this move as a breakout signal with a target of $0.1185-$0.13. However, there is caution that after a vertical rally, the price may retrace to the $0.0713-$0.0687 support level, requiring confirmation of a reversal pattern. Analysts suggest a short-term bullish strategy but warn of the risks of lacking sustained catalysts.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, for informational reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
New Non-Opioid Pain Relief Company Latigo (LTGO.US) Plans IPO to Raise Up to $288 Million, Nav1.8 Inhibitor Targets Vertex Pharmaceuticals (VRTX.US) Billion-Dollar Market
Pain therapy biotechnology company Latigo Biotherapeutics has finalized the terms for a $272 million IPO.
Euro holds ground as Eurozone growth data offsets oil-driven CAD gains
Earnings Preview | Pfizer (PFE.US) and Merck (MRK.US) Announce Results on the Same Day: As Patent Cliff Meets New Growth Engines, the Pharmaceutical Industry Faces a Valuation Test
Pfizer and Merck released their Q2 earnings report on the same day: one faces the major test of the “post-COVID era,” while the other is making a final push before the impending patent cliff for Keytruda.
Amazon (AMZN.US) surges 20% in two days: AWS's accelerated growth validates AI demand, concerns rise over capital expenditures and depreciation pressure
Some cautious market participants believe that what is truly validated for Amazon is the demand for AI, rather than the relationship between construction costs and actual economic returns. This suggests that Amazon’s stock price may once again come under pressure in the future due to the drag from capital expenditures.
Crypto prices
More
